Evidence map›Paper›PMID 28141867›Full record

ArticlePloS one2017

Adherence to Antiretroviral Therapy (ART) in Yaoundé-Cameroon: Association with Opportunistic Infections, Depression, ART Regimen and Side Effects.

Julius Y Fonsah, Alfred K Njamnshi, Charles Kouanfack, Fang Qiu, Dora M Njamnshi, Claude T Tagny, Emilienne Nchindap, Léopoldine Kenmogne, Dora Mbanya, Robert Heaton and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 3 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 3 syntheses or guidelines pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Julius Y FonsahDepartment of Neurology, Yaoundé Central Hospital, Yaoundé, Cameroon.
Alfred K NjamnshiDepartment of Neurology, Yaoundé Central Hospital, Yaoundé, Cameroon.
Charles KouanfackFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Fang QiuDepartment of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, NE, United States of America.
Dora M NjamnshiHIV-Day Care Service, Yaoundé Central Hospital, Yaoundé, Cameroon.
Claude T TagnyFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Emilienne NchindapYaoundé University Teaching Hospital, Yaoundé, Cameroon.
Léopoldine KenmogneYaoundé University Teaching Hospital, Yaoundé, Cameroon.
Dora MbanyaFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Robert HeatonDepartment of Psychiatry, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, United States of America.
Georgette D KanmogneDepartment of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE, United States of America.
Central Hospital of Yaoundé · CMUniversity Teaching Hospital of Yaounde · CMUniversité de Yaoundé I · CMUniversity of Nebraska Medical Center · USUniversity of California, San Diego · US

Funding

STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jessica Lynette Montoya · 2001 to 2026
$50.4M
HIV Genetic Diversity and Viral NeuropathogenesisR01MH094160 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI KANMOGNE, GEORGETTE D. · 2012 to 2016
$3.1M
NIMH NIH HHS P30 MH062512NIMH NIH HHS R01 MH094160
6 · The paper itself

Abstract

Following global efforts to increase antiretroviral therapy (ART) access in Sub-Saharan Africa, ART coverage among HIV-infected Cameroonians increased from 0% in 2003 to 22% in 2014. However, the success of current HIV treatment programs depends not only on access to ART, but also on retention in care and good treatment adherence. This is necessary to achieve viral suppression, prevent virologic failure, and reduce viral transmission and HIV/AIDS-related deaths. Previous studies in Cameroon showed poor adherence, treatment interruption, and loss to follow-up among HIV+ subjects on ART, but the factors that influence ART adherence are not well known. In the current cross-sectional study, patient/self-reported questionnaires and pharmacy medication refill data were used to quantify ART adherence and determine the factors associated with increased risk of non-adherence among HIV-infected Cameroonians. We demonstrated that drug side-effects, low CD4 cell counts and higher viral loads are associated with increased risk of non-adherence, and compared to females, males were more likely to forego ART because of side effects (p<0.05). Univariate logistic regression analysis demonstrated that subjects with opportunistic infections (on antibiotics) had 2.42-times higher odds of having been non-adherent (p<0.001). Multivariable analysis controlling for ART regimen, age, gender, and education showed that subjects with opportunistic infections had 3.1-times higher odds of having been non-adherent (p<0.0003), with significantly longer periods of non-adherence, compared to subjects without opportunistic infections (p = 0.02). We further showed that compared to younger subjects (≤40 years), older subjects (>40 years) were less likely to be non-adherent (p<0.01) and had shorter non-adherent periods (p<0.0001). The presence of depression symptoms correlated with non-adherence to ART during antibiotic treatment (r = 0.53, p = 0.04), and was associated with lower CD4 cell counts (p = 0.04) and longer non-adherent periods (p = 0.04). Change in ART regimen was significantly associated with increased likelihood of non-adherence and increased duration of the non-adherence period. Addressing these underlying risk factors could improve ART adherence, retention in care and treatment outcomes for HIV/AIDS patients in Cameroon.

Indexed as

Medication AdherenceAcquired Immunodeficiency SyndromeAdultAntiretroviral Therapy, Highly ActiveCameroonCD4 Lymphocyte CountClinical Trials as TopicDemographyDepressionFemaleHumansMaleOpportunistic InfectionsRisk FactorsSelf ReportSurveys and Questionnaires

Identifiers

PMID28141867
PMCPMC5283684
OpenAlexW2583549189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.